I dont believe cancer vaccines are in the interest of GSK.
That was a reply I got around 6 - 8 months back when I highlighted PRR to Christopher Francis at GSK, who heads up the Oncology business development unit. Maybe times have changed or that was a throw away line..........
See the attached link and feel free to email him:
www.gsk.com/collaborations/downloads/WWBD-mini-brochure.pdf
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $225.8K | 931.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 288990 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 21838 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |